Banzel Oral Suspension Approved as Adjunct Therapy for Seizures - MPR
Links shared publicly online about this topic.
- 464total visits
Banzel Oral Suspension Approved as Adjunct Therapy for Seizures - MPR
empr.com —
View full resource at empr.com
Tags: Seizure, Disease and Condition, FDA, Eisai, News
Most Recently Shared on March 4, 2011 at 3:28 pm By:
MPR News: Banzel Oral Suspension Approved as Adjunct Therapy for Seizures: The FDA has approved Banzel (rufinami... http://bit.ly/dGLofF
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL
medicalnewstoday.com — “Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BANZEL® (rufinamide) Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated wit” View full resource at medicalnewstoday.com
Most Recently Shared on March 7, 2011 at 9:05 am By:
MNT Pediatrics News Pediatrics and Health News
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL http://mnt.to/3RTV #pediatrics
Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS
news-medical.net — “Eisai Inc. today announced that the U.S. Food and Drug Administration has approved BANZEL Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.” View full resource at news-medical.net
Most Recently Shared on March 4, 2011 at 5:02 am By:
News-Medical.Net Health News and Oncology
Oncology News: Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS: Eisai I... http://bit.ly/h6IkTL
Advertisement
